Non Surgical Protocol for Treatment of Peri-implantitis
Evaluation of the Adjunctive Use of Er:YAG Laser or Erythritol Air-polishing in the Non-surgical Treatment of Peri-implantitis: a RCT
1 other identifier
interventional
47
1 country
1
Brief Summary
Peri-implantitis is an important disease entity as a result of its high prevalence and the lack of a standard mode of therapy. Non-surgical therapy of peri-implant disease, especially when bone loss is not high, appears to be partially effective in resolving the disease. In several cases, however, only limited improvements have been reported in the main clinical parameters (bleeding at the survey and presence of the pocket) and there is a clear tendency to relapse of the disease. In these cases it is therefore recommended to consider adjunctive therapies. Numerous approaches have been used for implant surface decontamination including mechanical, chemical and treatments by means of air-powder or laser. The aim of the present randomized controlled clinical trial will be to assess the efficacy in improving clinical parameters of two further methods of implant surface decontamination (Er:YAG laser or air-abrasive device) after mechanical cleaning during non surgical treatment of peri-implantitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2018
CompletedFirst Posted
Study publicly available on registry
March 2, 2018
CompletedStudy Start
First participant enrolled
December 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 6, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 6, 2021
CompletedDecember 29, 2025
December 1, 2025
2.8 years
February 20, 2018
December 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
probing pocket depth changes
changes in probing pocket depth, measured from the mucosal margin to the bottom of the pocket
baseline, 1, 3, 6 months
Secondary Outcomes (2)
Bleeding on probing changes
baseline,1, 3, 6 months
endpoint of therapy
1,3,6 months
Study Arms (3)
Mechanical instrumentation with curettes
SHAM COMPARATORmechanical instrumentation: Inflammatory tissue, excess cement or plaque deposits will be removed using hand instruments (titanium curettes) and the implant surface will be cleaned.
Er:YAG laser
EXPERIMENTALEr:YAG laser treatment will be provided on the implant surface.
Air Powder
ACTIVE COMPARATORan Air-Powder treatment will be provided on the implant surface.
Interventions
mechanical debridement: Inflammatory tissue, excess cement or plaque deposits will be removed using hand instruments (titanium curettes) and the implant surface will be cleaned. Furthermore, Er:YAG laser treatment will be provided on the implant surface.
mechanical debridement: Inflammatory tissue, excess cement or plaque deposits will be removed using hand instruments (titanium curettes) and the implant surface will be cleaned. Furthermore, an Air-Powder treatment will be provided on the implant surface.
mechanical debridement: Inflammatory tissue, excess cement or plaque deposits will be removed using hand instruments (titanium curettes) and the implant surface will be cleaned
Eligibility Criteria
You may qualify if:
- presence of at least one screw-type titanium implant exhibiting bleeding and/or suppuration on probing combined with:
- a PPD ≥ 5 mm and bone loss \> 2 mm (compared to crestal bone levels at the time of placement of the reconstruction)
- a PPD ≥ 6 mm and bone loss ≥ 3 mm (not compared to crestal bone levels at the time of placement of the reconstruction)
- single tooth and bridgework restorations without overhangings
- no evidence of occlusal overload (i.e. occlusal contacts revealed appropriate adjustment)
- implant function time ≥ 1 year.
You may not qualify if:
- Patients with uncontrolled diabetes,
- patients with osteoporosis or under bisphosphonate medication,
- pregnant or lactating women,
- patients with a history of radiotherapy to the head and neck region
- patients with incapability to perform basal oral hygiene measures due to physical or mental disorders
- hollow implants
- implant mobility
- implants at which no position could be identified where proper probing measurements could be performed;
- previous surgical treatment of the peri-implantitis lesions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Università Vita-Salute San Raffaele
Milan, Milano, 20100, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Massimo De Sanctis, Prof.
University Vita Salute San Raffaele
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 20, 2018
First Posted
March 2, 2018
Study Start
December 2, 2018
Primary Completion
October 6, 2021
Study Completion
October 6, 2021
Last Updated
December 29, 2025
Record last verified: 2025-12